The Decision on Priority
By Kevin E. Noonan –
On March 26, the Patent Trial and Appeal Board, without holding an oral hearing and despite a rather sharply worded opinion by the Federal Circuit vacating and remanding its earlier priority
By Donald Zuhn –
Earlier this year, Argentine intellectual property law firm Berken IP reported that Argentina had signed a Reciprocal Trade and Investment Agreement with the United States that included several commitments to harmonize its intellectual property system with international standards.
By Dunstan Barnes, Catalina “Caty” Medrano, and Tristan Morgan –
On March 12, 2026, U.S. Patent and Trademark Office Director John A. Squires announced new supplemental guidance regarding examination of design patent applications related to computer-generated interfaces and
By Kevin E. Noonan –
The course of the proceedings involving the attempts to remove Judge Pauline Newman from the Federal Circuit is long, and in many senses tragic (see links below). Just when you might think the last Act
Despite a pointed decision by the Federal Circuit vacating and remanding the matter to the Patent Trial and Appeal Board, yesterday the Board once again granted priority for CRISPR technology to the Broad Institute. A more detailed discussion of the
By Kevin E. Noonan –
The Parties – Senior Party Broad Institute, Harvard University, and MIT (collectively, “Broad”) and Junior Party Regents of the University of California, Berkeley; University of Vienna; and Emmanuelle Charpentier (collectively “CVC”) – each timely filed
By Michael Borella –
Among the many failings of the current U.S. patent eligibility framework under 35 U.S.C. § 101, perhaps none is more corrosive to the patent system’s basic function than the fact that the framework keeps changing. The
By Kevin E. Noonan –
Neither the Parties nor the Patent Trial and Appeal Board (PTAB) have been resting in addressing the decision by the Federal Circuit that vacated and remanded the Board’s decision awarding priority in Interference No. 106,115
By Kevin E. Noonan –
The course of the proceedings involving the attempts to remove Judge Pauline Newman from the Federal Circuit is long and in many senses tragic (see links below). Last week the latest, and likely last, Act
By Kevin E. Noonan –
One of the beneficial characteristics of the response to the COVID-19 pandemic were pledges from companies involved in developing vaccines (such as Moderna, Pfizer, BioNTech and others) not to enforce patents on relevant technology during
